Clinical trial
Disulfiram in Patients With Metastatic Melanoma
NCT00256230 · John P. Fruehauf, Other · Completed
Key facts
| NCT number | NCT00256230 |
|---|---|
| Title | Disulfiram in Patients With Metastatic Melanoma |
| Official title | Evaluation of Disulfiram in Patients With Metastatic Melanoma and at Least One Prior Systemic Therapy, Phase I/II |
| Lead sponsor | John P. Fruehauf, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Stage IV Melanoma |
| Intervention type | Drug |
| Interventions | Disulfiram (DSF) |
| Enrollment | 7 |
| Start date | Jan 1, 2002 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Nov 21, 2005 |
| Last update posted | Dec 8, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: